Filing Details
- Accession Number:
- 0001773751-25-000102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-18 18:35:38
- Reporting Period:
- 2025-03-14
- Filing Date:
- 2025-03-18
- Accepted Time:
- 2025-03-18 18:35:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1773751 | Hims & Hers Health Inc. | HIMS | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1839736 | Harrison Patrick Carroll | 2269 Chestnut Street, #523 San Francisco CA 94123 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2025-03-14 | 36,275 | $0.00 | 236,110 | No | 4 | M | Direct | |
Class A Common Stock | Disposition | 2025-03-14 | 3,162 | $33.14 | 232,948 | No | 4 | F | Direct | |
Class A Common Stock | Disposition | 2025-03-18 | 23,287 | $34.31 | 209,661 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Restricted Stock Unit | Disposition | 2025-03-14 | 8,148 | $0.00 | 8,148 | $0.00 |
Class A Common Stock | Restricted Stock Unit | Disposition | 2025-03-14 | 4,840 | $0.00 | 4,840 | $0.00 |
Class A Common Stock | Restricted Stock Unit | Disposition | 2025-03-14 | 23,287 | $0.00 | 23,287 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
57,041 | No | 4 | M | Direct | ||
58,075 | No | 4 | M | Direct | ||
0 | No | 4 | M | Direct |
Footnotes
- The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU.
- The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 8, 2024 by the Reporting Person
- The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on December 15, 2023, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments over the following 3 years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date") occurring thereafter.
- The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024.
- The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a three-year period, with (i) one-third of the RSUs vesting on March 15, 2023, (ii) one-third of the RSUs vesting on March 15, 2024 and (iii) one-third of the RSUs vesting on March 15, 2025.